Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT): A Multicenter, Randomized, Sham-controlled, Feasibility Device Trial.

NCT05447650 is registered in ClinicalTrials.gov with i-Lumen Scientific, Inc. as lead sponsor.

NCT NCT05447650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05447650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT): A Multicenter, Randomized, Sham-controlled, Feasibility Device Trial.
Lead sponsor
i-Lumen Scientific, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 12, 2022
Completion date
June 15, 2025
Enrollment
95 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, dry age-related macular degeneration, nonexudative age-related macular degeneration